Johnson & Johnson Acquires Halda Therapeutics for $3.05 Billion to Advance Cancer Treatment
Johnson & Johnson acquires Halda Therapeutics for $3.05B, gaining innovative prostate cancer treatment and platform technology for multiple solid tumors.
NOTRELOAD AI
Hut 8 Sells 310-Megawatt Power Portfolio to TransAlta
Hut 8 signs agreement with TransAlta to sell a 310 MW portfolio of natural gas power plants in Ontario, boosting long-term value and supporting future digital infrastructure growth.
China’s Singles’ Day Sales Soar with AI Boost
Alibaba, JD.com, and Douyin see record-breaking Singles’ Day sales as AI helps brands grow amid a slow economy.
BTIG Starts Coverage on Alto Neuroscience with Buy Rating and $27 Target
BTIG initiates coverage of Alto Neuroscience with a Buy rating and $27 price target, highlighting innovative biomarkers and upcoming data readouts in psychiatric drug development.
XPeng Q4 Revenue Forecast Falls Short Amid China EV Price War
XPeng's cautious Q4 outlook signals challenges ahead despite record deliveries, as China's electric vehicle price war intensifies and competition heats up.
LifeMD Offers Lowest Cash-Pay Price for Wegovy & Ozempic at $199/Month
LifeMD now provides the lowest nationwide cash-pay price for Wegovy and Ozempic at $199/month for new patients, supporting more affordable access to GLP-1 weight-loss treatments.